On February 13, 2023, Interon Laboratories, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37,600 KRW | +1.76% | +12.07% | -15.12% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.12% | 1.38B | |
+37.97% | 705B | |
+32.82% | 583B | |
-3.65% | 364B | |
+19.90% | 332B | |
+5.34% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.35% | 169B |
- Stock Market
- Equities
- A009420 Stock
- News Hanall Biopharma Co., Ltd.
- Interon Laboratories, Inc. announced that it has received funding from Hanall Biopharma Co., Ltd.